These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 29893471
1. Unfavorable presentation but comparable outcome: Presentation and outcome of children with nodular lymphocyte predominant Hodgkin lymphoma from India. Prasad M, Narula G, Chinnaswamy G, Arora B, Shet T, Panjwani P, Sengar M, Laskar S, Khanna N, Banavali S. Pediatr Blood Cancer; 2018 Oct; 65(10):e27288. PubMed ID: 29893471 [Abstract] [Full Text] [Related]
2. High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only. van Grotel M, Lam KH, de Man R, Beishuizen A, Pieters R, van den Heuvel-Eibrink MM. Leuk Lymphoma; 2006 Aug; 47(8):1504-10. PubMed ID: 16966260 [Abstract] [Full Text] [Related]
3. Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle East. Akhtar S, Rauf MS, Khafaga Y, Al-Kofide A, Elhassan TAM, Elshenawy MA, Nadri J, Mushtaq AH, Bakshi N, Shamayel M, Al-Sweedan S, Sarwar S, Maghfoor I. BMC Cancer; 2021 Apr 01; 21(1):351. PubMed ID: 33794818 [Abstract] [Full Text] [Related]
4. A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma. Strobbe L, Valke LL, Diets IJ, van den Brand M, Aben K, Raemaekers JM, Hebeda KM, van Krieken JH. Ann Hematol; 2016 Feb 01; 95(3):417-23. PubMed ID: 26732883 [Abstract] [Full Text] [Related]
5. Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma. Sohani AR, Jaffe ES, Harris NL, Ferry JA, Pittaluga S, Hasserjian RP. Am J Surg Pathol; 2011 Nov 01; 35(11):1666-78. PubMed ID: 21997687 [Abstract] [Full Text] [Related]
7. Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)-clinicopathological features based on the data of two Hungarian lymphoma centres. Illés A, Simon Z, Tóth E, Rosta A, Miltényi Z, Molnár Z. Pathol Oncol Res; 2008 Dec 01; 14(4):411-21. PubMed ID: 18431694 [Abstract] [Full Text] [Related]
8. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis. Gerber NK, Atoria CL, Elkin EB, Yahalom J. Int J Radiat Oncol Biol Phys; 2015 May 01; 92(1):76-83. PubMed ID: 25863756 [Abstract] [Full Text] [Related]
9. Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base. Olszewski AJ, Shrestha R, Cook NM. Cancer; 2015 Oct 01; 121(19):3472-80. PubMed ID: 26149294 [Abstract] [Full Text] [Related]
11. [Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management]. Gorde-Grosjean S, Guimard G, Lambilliotte A, Coulomb-Lhermine A, Montravers F, Landman-Parker J. Bull Cancer; 2014 Sep 01; 101(9):881-90. PubMed ID: 25296072 [Abstract] [Full Text] [Related]
12. Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG. Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang R, Dickinson M, Ng AK, Roberts KB, Gao S, Balogh A, Ricardi U, Levis M, Casulo C, Stolten M, Specht L, Plastaras JP, Wright C, Kelsey CR, Brady JL, Mikhaeel NG, Hoppe BS, Terezakis SA, Picardi M, Della Pepa R, Kirova Y, Akhtar S, Maghfoor I, Koenig JL, Jackson C, Song E, Sehgal S, Advani RH, Natkunam Y, Constine LS, Eich HT, Wirth A, Hoppe RT. Blood; 2020 Jun 25; 135(26):2365-2374. PubMed ID: 32211877 [Abstract] [Full Text] [Related]
17. Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network. Farrell K, McKay P, Leach M. Leuk Lymphoma; 2011 Oct 25; 52(10):1920-8. PubMed ID: 21663507 [Abstract] [Full Text] [Related]
18. Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible? Laskar S, Kumar DP, Khanna N, Menon H, Sengar M, Arora B, Gujral S, Shet T, Sridhar E, Rangarajan V, Muckaden MA, Nair R, Banavali S. Leuk Lymphoma; 2014 Oct 25; 55(10):2356-61. PubMed ID: 24354681 [Abstract] [Full Text] [Related]
19. The Role of Radiation in All Stages of Nodular Lymphocytic Predominant Hodgkin Lymphoma. Odei B, Boothe D, Frandsen J, Poppe MM, Gaffney DK. Clin Lymphoma Myeloma Leuk; 2017 Dec 25; 17(12):819-824. PubMed ID: 29051078 [Abstract] [Full Text] [Related]
20. Childhood and Adolescent nodular lymphocyte predominant Hodgkin lymphoma - A review of clinical outcome based on the histological variants. Shankar AG, Kirkwood AA, Hall GW, Hayward J, O'Hare P, Ramsay AD. Br J Haematol; 2015 Oct 25; 171(2):254-262. PubMed ID: 26115355 [Abstract] [Full Text] [Related] Page: [Next] [New Search]